Melanoma, Quality of Life, Lymphedema, Depression, Anxiety, Pain, Cicatrix
Conditions
Brief summary
Health-related Quality of life in Danish stage IB-III cutaneous melanoma patients.
Detailed description
The aim of the PhD-study is to evaluate, in a large cohort of Danish melanoma patients: 1. Health-related quality of life assessing psychological, physical and social well-being 2. Physical long term side effects (lymphoedema, scarring and neuropathic pain) 3. Lymphoedema assessed by clinical examination and DXA scans
Interventions
RADIATIONDXA scan
DXA scan
PROCEDUREClinical examination
Clinical examination
Sponsors
Danish Cancer Society
Herlev Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* AJCC stage IB-III cutaneous melanoma patients * At least one year follow-up after melanoma surgery
Exclusion criteria
* Pregnancy * Bilateral axilla or groin melanoma surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Global Health Score | 12 months | Quality of life will be assessed with the questionnaire EORTC QLQ-C30 v.3.0 |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety | 12 months | Anxiety will be assessed with the questionnaire Hospital Anxiety and Depression Scale (HADS) |
| Depression | 12 months | Depression will be assessed with the questionnaire Hospital Anxiety and Depression Scale (HADS) |
| Lymphoedema | 12 months | Lymphoedema will be assessed with a questionnaire including the LYMQOL questionnaire, clinical examination and DXA scan |
| Neuropathic pain | 12 months | Neuropathic pain will be assessed with a questionnaire including painDetect |
| Volume and tissue composition assessed with DXA scan | 12 months | DXA scan |
Countries
Denmark
Outcome results
None listed